IN the last four decades the Rhesus problem has been defined; its cause then identified, leading on to a rational treatment which for a time was available to the baby after birth but later extended to the baby before birth; culminating in the grand finale-disease prevention. Unfortunately that grand finale, despite the optimism of the seventies, had not yet been reached. DISCOVERY OF THE RHESUS BLOOD GROUP For many years, doctors had realised that there was a heterogeneous group of newborn babies who developed jaundice, anaemia or both, which were variants of a single underlying disorder, characterised by haemolysis and erythroblastosis. In 1940, Landsteiner and Wiener' published a paper of less than 20 lines in which they described the discovery of the Rhesus blood group system. In the following year Levine2 reported that haemolytic disease of the newborn or in some cases a stillbirth, was due to incompatibility between mother and fetus.
The next developments took place in England where Fisher,3 working in Cambridge, predicted and later proposed an alternative notation to the Rh/hr suggested by Wiener. His CDE/cde notation is now accepted throughout the world. Coombs,4 working in the same laboratory, developed a technique for detecting Rhesus antibodies. This test is also used throughout the world.
Seventeen per cent of women in the British Isles are Rhesus negative, and lack of this antigens is designated by the letters d/d. It has been calculated' that three of the seventeen will marry Rhesus negative husbands, six will marry homozygous Rhesus positive (D/D) husbands with a 1:12 chance of the second child being affected, while eight will marry heterozygous Rhesus positive (D/d) husbands with a chance of the second baby being affected in 1:15.
CLINICAL BACKGROUND
Before the introduction of Rhesus prophylaxis the incidence of the disease was 1: 200 of all pregnancies. Rhesus negative women became sensitised during the first pregnancy, usually during the third stage of labour as the placenta separated. Minor degrees of placental separation may occur during pregnancy, e.g., threatened abortion, antepartum haemorrhage during external cephalic version and amniocentesis, and play a part in the sensitisation of a small number of patients. Following sensitisation, in any subsequent pregnancy, if the fetus is Rhesus positive, antibodies will be produced. Formerly, blood transfusion had been a major factor in the production of antibodies. Donald5 reported that pre-1950 over one-third of all patients with antibodies gave a history of blood transfusion.
For many years the only treatment available was a direct transfusion of blood to the baby after birth-often the father's Rhesus positive blood being used! Rhesus negative blood was given after its discovery. Wallestein6 in New York described the first "exsanguination-replacement" transfusions. In this procedure he inserted one needle into the superior saggital sinus and a second needle into the umbilical vein. The "exchange" transfusion as performed today only became a reality after the development of the plastic tubing and its introduction into medical practice. In 1947, Diamond7 brought samples of tubing to Britain and introduced the exchange transfusion. The first such transfusion was performed in Belfast in 1948. 8 The perinatal mortality remained high so premature induction of labour was considered as another means of improving the results. The Medical Research Council initiated a multicentre controlled trial into the management of patients with antibodies. Two problems were considered-1) the routine induction of premature labour at three or five weeks before term versus the onset of spontaneous labour, and 2) exchange transfusion versus direct transfusion to the baby. Northern Ireland was represented on the supervising committee by Dr W.A.B. Campbell and all patients in the Belfast teaching hospitals were used in the trial. The results are shown in Table I . The authors9 concluded that babies born spontaneously at term had a lower mortality than those born prematurely and that exchange transfusion was a better form of treatment than simple direct transfusion. THE LOCAL SCENE In July 1948, the National Health Service was established. No consultant obstetricians had been based outside Belfast nor were maternity beds available apart from those in the Belfast hospitals. Thus, in 1948, there were only 12 patients with antibodies delivered in the Royal Maternity Hospital, Belfast. The importance of centralisation and the need for paediatric help was obvious. As consultant obstetricians were appointed to peripheral hospitals, patients with antibodies were transferred to Belfast for treatment. In 1956, 63 patients with antibodies had been delivered in the Royal Maternity Hospital, and 15 babies born elsewhere admitted for treatment, while in Jubilee Maternity Hospital 32 patients were delivered and 6 infants transferred for treatment. 8 Professor C.H.G. Macafee did not accept the results of the MRC trial and instead advocated a policy of selective induction of premature labour. His views were supported by Kelsall and Vos'0 who reported a loss of only 10.7 per cent in infants delivered by premature induction of labour, compared with a loss of 23.4 per cent in those delivered spontaneously at term. Fisher"I published a series from Royal Maternity Hospital which showed that selective planned induction of labour-as distinct from the MRC routine induction of labour-resulted in a lower fetal loss of 16 per cent as compared with 29 per cent in a similar group delivered at term (Table II) . Fisher also pointed out that those infants delivered following induction of labour were from mothers with a bad Rhesus history and required twice as many exchange transfusions as those delivered at term. Campbell'2 reported that a high potassium level in stored citrated blood had toxic effects on many babies during exchange transfusion and recommended that freshly collected heparinised blood should be used for the exchange transfusion. In selecting patients for induction of labour, Professor Macafee admitted such women not later than the thirty-sixth week of the pregnancy. The indications for induction were, to a certain extent, arbitrary, e.g., the history of a previously affected or stillborn infant due to haemolytic disease, a rising antibody titre and a homozygous Rhesus positive father were important factors. During the latter weeks of pregnancy any diminution of fetal movements reported by the patient or an alteration in the fetal heart noted by the midwife were indications for immediate delivery.
CONTINUING RESEARCH Obviously there was a need for a specific test to help in selecting patients for induction of labour. In 1950, Bevis'3 in Manchester commenced studies on the liquor obtained by hindwater rupture at the time of induction of labour. In 1956's he reported that measurement of the bilirubin content of the liquor obtained by amniocentesis during the pregnancy was the best indicator of fetal wellbeing. This test has become the yardstick by which the severity of the disease is measured. The test was improved by Liley'3 who in turn produced the results on a graphic form in which the degree of severity of the affected fetus was recorded in three zones-mild, moderate and severe. Amniocentesis in the management of patients with antibodies was introduced in the Waveney Hospital by Vernon Parry,'6 a former colleague of Bevis.
Amniocentesis is not without risk. In a series of 410 amniocentesis performed prior to placental localisation, Peddle'7 reported that transplacental haemorrhage from fetus to mother occurred in 11. 2 OTHER TREATMENT About the late 1950's phototherapy was introduced into the management of the babies. This treatment followed the observation of a ward sister who noted that jaundice faded quickly in those babies who had been exposed for a short time to sunlight. Though there seems no doubt that this is true, the consensus of opinion seems to be that the therapy is of more benefit in jaundice associated with prematurity than in that due to Rhesus disease '20 Liley2" published details of the use of intra-uterine fetal transfusion in an effort to prevent stillbirth or the delivery of very severely affected babies. This procedure was enthusiastically adopted in many centres. In 1964 the first such procedure was performed in Jubilee Maternity Hospital, Belfast. 22 In the following year the first intra-uterine transfusion was performed in Royal Maternity Hospital.23
In an attempt to protect the baby from high levels of antibodies while in utero the technique of plasmapharesis was introduced. The results are difficult to evaluate, as other methods of treatment are also given simultaneously, e.g., intra-uterine fetal transfusion. It is possible, however, that repeated plasmapharesis lowers the affinity of the Rhesus antibody and this may explain the apparent success of the procedure. 24 The method was not found rewarding in Belfast.
In 1968, Whitfield25 introduced his "Action Line" which was superimposed on Liley's zones. While Liley had predicted the severity of the disease, different managements of the patient were advocated by various workers. Whitfield based his recommendation on the results of two bilirubin estimations. This was later modified26 when liquor studies of the lecithin sphingomyelin area ratio (LSAR) became available. This test is used to estimate the maturity of the fetal lungs. Obviously, if the result was good the baby could be delivered knowing that there would be no respiratory problems in addition to the haemolytic problem. Likewise, if the test was poor then intra-uterine fetal transfusion was needed. The number of intra-uterine transfusions in Royal Maternity Hospital is shown in Table III . The dramatic fall is due mainly to the changes in management and the virtual disappearance of the "grand multipara". 13 1981 1 1 PROPHYLAXIS The extraordinary story of how an amateur interest in butterflies which had led Clarke27 to start work on genetics which eventually turned from butterflies to the human blood groups is well known. This led to the discovery that fetal Rhesuspositive cells in the maternal blood could be destroyed by administering anti-D in the form of gammaglobulin to the mother in the puerperium. At about the same time in the United States of America, Freda et al28 were achieving similar clinical results, although they had arrived at their conclusions by a different route. Their story is no less bizarre-using volunteers from Sing-Sing Prison as their original subjects.
Routine prophylaxis by the injection of 100 mg of anti-D gammaglobulin within 72 hours of delivery to a Rhesus negative woman who had been delivered of a Rhesus positive baby was introduced in 1970. 29 In 1968 this was given to selected patients following delivery. This was due to the small volume of supplies available. Only in 1971 was routine prophylaxis made available here to all women who required this treatment. The dramatic fall in the number of women with antibodies delivered in Royal Maternity Hospital is shown in Table IV . This is mainly due to prophylaxis but also to the ready availability of contraceptive advice. The Standing Medical Advisory Committee Report on the Prevention of Rhesus Disease" recommended that anti-D be given after spontaneous abortions. This had not been the practice in Northern Ireland. An addendum recommending further indications for the use of-anti-D is currently being considered. This would include indications such as routine prophylaxis after external cephalic version, etc.
Some women are still developing antibodies. McClelland and McLoughlin3' reported some disturbing figures from the province (Table V) . Obviously, there is room for improvement as some of the patients did not receive anti-D. This applies particularly to those women who abort at home before their blood group is known and to those few women who are delivered at home. With the present methods it is accepted that prophylaxis will fail in 2 per cent of those women who have received 
OTHER RHESUS ANTIBODIES
There are a small number of patients with antibodies other than D. There is no prophylaxis against these. It is of interest that there has been no drop in the numbers. The patients from Royal Maternity Hospital have been discussed in detail. 33 Anti-E has not been a problem but C and c antibodies may severely affect the fetus and the patients must be carefully supervised. It should be noted that thse antibodies may be found in Rhesus positive patients. Obviously, as prophylaxis against the D antibody continues these others will eventually form the major part of the problem. CONCLUSION The story of the Rhesus disease is fascinating, especially as so much, from diagnosis to prevention, has taken place in a very short time. Doctors from many countries have contributed to this. The importance of "teamwork" has been shown-obstetrician, neonatologist, haematologist and physician combining to produce a good end result. Northern Ireland doctors have played an important role in influencing opinion in the United Kingdom.
Complacency must not develop while that "grand finale"-elimination of all anti-D antibodies-has not yet been achieved. We must continually be on our guard to ensure that anti-D gammaglobulin is always given when required and we await the recommendations of the present British research workers which will reduce the disease even further.
